carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Generic Opana ER® Launches
Released: 01/15/2013
By: Mike Partridge, RPh

On January 7, 2013, Global Pharmaceutical received final FDA approval for and commenced shipping the generic equivalent for Endo’s branded product, Opana ER® (oxymorphone HCL) tablets. Opana ER® had estimated total U.S. annual sales of approximately $25 million.

Opana is an opioid agonist indicated for the relief of moderate to severe pain in patients requiring continuous around the clock opioid treatment for an extended period of time

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer